SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-051944
Filing Date
2024-04-25
Accepted
2024-04-25 16:01:05
Documents
13
Period of Report
2024-04-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2412702d1_8k.htm   iXBRL 8-K 27537
  Complete submission text file 0001104659-24-051944.txt   201961

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA immu-20240425.xsd EX-101.SCH 3015
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20240425_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20240425_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2412702d1_8k_htm.xml XML 3688
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 24876033
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)